Different expressionofubiquitinC-terminal hydrolase-L1 and αiI-spectrin inischemic and hemorrhagicstroke:Potentialbiomarkers in diagnosis

Brain Research

Volumn 1540, Issue , 2013, Pages 84-91

  Ren, Changhong ^a,c   ZoItewicz, Susie ^b,c   Guingab Cagmat, Joy ^b,c   Anagli, John ^b,c   Gao, Mingqing ^a   Hafeez, Adam ^d   Li, Ning ^a,c   Cao, Jinqiang ^a   Geng, Xiaokun ^a   Koheissy, Firas ^e   Mondello, Stefania ^b   Larner, Stephen F ^b,c   Hayes, Ronald L ^b,c   Ji, Xunming ^a,c   Ding, Yuchuan ^a,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BANYAN BIOMARKERS INC   (United States)

^c Xuanwu Banyan Biomarker Research and Assay Center   (China)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarker; Hemorrhagia; Ischemia; Stroke; Ubiquitin C terminal hydrolase L1; II Spectrin

Indexed keywords

ALPHA II SPECTRIN; BIOLOGICAL MARKER; GELATINASE A; SPECTRIN; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; UCH L1 PROTEIN, RAT; UCH-L1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIA; IMMUNOBLOTTING; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; WESTERN BLOTTING; ΑII-SPECTRIN; ANIMAL; BLEEDING; BLOOD; BRAIN; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; ISCHEMIA; MALE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; UBIQUITIN C-TERMINAL HYDROLASE-L1;

FICUS BENGHALENSIS; RATTUS;

ΑII-SPECTRIN; BIOMARKER; HEMORRHAGIA; ISCHEMIA; STROKE; UBIQUITIN C-TERMINAL HYDROLASE-L1;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; DISEASE MODELS, ANIMAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPECTRIN; STROKE; UBIQUITIN THIOLESTERASE;

EID: 84901855694     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.09.051     Document Type: Article

References (33)

1. Allard, L., Lescuyer, P., Burgess, J., Leung, K.Y., Ward, M., Walter, N., Burkhard, P.R., Corthals, G., Hochstrasser, D.F., Sanchez, J.C., 2004. ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics 4, 2242-2251.
2. Beer, R., Franz, G., Srinivasan, A., Hayes, R.L., Pike, B.R., Newcomb, J.K., Zhao, X., Schmutzhard, E., Poewe, W., Kampfl, A., 2000. Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury. J. Neurochem. 75, 1264-1273.
3. Brophy, G.M., Pineda, J.A., Papa, L., Lewis, S.B., Valadka, A.B., Hannay, H.J., Heaton, S.C., Demery, J.A., Liu, M.C., Tepas III., J.J., Gabrielli, A., Robicsek, S., Wang, K.K., Robertson, C.S., Hayes, R.L., 2009. alpha II-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. J. Neurotrauma 26, 471-479.
4. Cardali, S., Maugeri, R., 2006. Detection of alpha II-spectrin and breakdown products in humans after severe traumatic brain injury. J. Neurosurg. Sci. 50, 25-31.
5. Chalela, J.A., Kidwell, C.S., Nentwich, L.M., Luby, M., Butman, J.A., Demchuk, A.M., Hill, M.D., Patronas, N., Latour, L., Warach, S., 2007. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 369, 293-298.
6. Cuadrado, E., Rosell, A., Colome, N., Hernandez-Guillamon, M., Garcia-Berrocoso, T., Ribo, M., Alcazar, A., Ortega-Aznar, A., Salinas, M., Canals, F., Montaner, J., 2010. The proteome of human brain after ischemic stroke. J. Neuropathol. Exp. Neurol. 69, 1105-1115.
7. Cunningham, R.T., Young, I.S., Winder, J., O'Kane, M.J., McKinstry, S., Johnston, C.F., Dolan, O.M., Hawkins, S.A., Buchanan, K.D., 1991. Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur. J. Clin. Invest. 21, 497-500.
8. Dambinova, S.A., Khounteev, G.A., Izykenova, G.A., Zavolokov, I.G., Ilyukhina, A.Y., Skoromets, A.A., 2003. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem. 49, 1752-1762.
9. Ding, Y., Li, J., Rafols, J.A., Phillis, J.W., Diaz, F.G., 2002. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats. Stroke 33, 2492-2498.
10. Dvorak, F., Haberer, I., Sitzer, M., Foerch, C., 2009. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc. Dis. 27, 37-41.
11. Foerch, C., Curdt, I., Yan, B., Dvorak, F., Hermans, M., Berkefeld, J., Raabe, A., Neumann-Haefelin, T., Steinmetz, H., Sitzer, M., 2006. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J. Neurol. Neurosurg. Psychiatry 77, 181-184.
12. Foerch, C., Montaner, J., Furie, K.L., Ning, M.M., Lo, E.H., 2009. Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology 73, 393-399.
13. Hall, E.D., Sullivan, P.G., Gibson, T.R., Pavel, K.M., Thompson, B.M., Scheff, S.W., 2005. Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. J. Neurotrauma 22, 252-265.
14. Jackson, P., Thompson, R.J., 1981. The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis. J. Neurol. Sci. 49, 429-438.
15. Kent, D.M., Ruthazer, R., Selker, H.P., 2003. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?. Stroke 34, 464-467.
16. Larsen, C.N., Price, J.S., Wilkinson, K.D., 1996. Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues. Biochemistry 35, 6735-6744.
17. Lescuyer, P., Allard, L., Zimmermann-Ivol, C.G., Burgess, J.A., Hughes-Frutiger, S., Burkhard, P.R., Sanchez, J.C., Hochstrasser, D.F., 2004. Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration. Proteomics 4, 2234-2241.
18. Lewis, S.B., Velat, G.J., Miralia, L., Papa, L., Aikman, J.M., Wolper, R.A., Firment, C.S., Liu, M.C., Pineda, J.A., Wang, K.K., Hayes, R.L., 2007. Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: a novel biomarker of proteolytic injury. J. Neurosurg. 107, 792-796.
19. Liu, M.C., Akinyi, L., Scharf, D., Mo, J., Larner, S.F., Muller, U., Oli, M.W., Zheng, W., Kobeissy, F., Papa, L., Lu, X.C., Dave, J.R., Tortella, F.C., Hayes, R.L., Wang, K.K., 2010. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur. J. Neurosci. 31, 722-732.
20. Lloyd-Jones, D., Adams, R.J., Brown, T.M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T.B., Ford, E., Furie, K., Gillespie, C., Go, A., Greenlund, K., Haase, N., Hailpern, S., Ho, P.M., Howard, V., Kissela, B., Kittner, S., Lackland, D., Lisabeth, L., Marelli, A., McDermott, M.M., Meigs, J., Mozaffarian, D., Mussolino, M., Nichol, G., Roger, V.L., Rosamond, W., Sacco, R., Sorlie, P., Stafford, R., Thom, T., Wasserthiel-Smoller, S., Wong, N.D., Wylie-Rosett, J., 2010. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121, 948-954.
21. Longa, E.Z., Weinstein, P.R., Carlson, S., Cummins, R., 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91.
22. Matias-Guiu, J., Martinez-Vazquez, J., Ruibal, A., Colomer, R., Boada, M., Codina, A., 1986. Myelin basic protein and creatine kinase BB isoenzyme as CSF markers of intracranial tumors and stroke. Acta Neurol. Scand. 73, 461-465.
23. Matsushita, K., Meng, W., Wang, X., Asahi, M., Asahi, K., Moskowitz, M.A., Lo, E.H., 2000. Evidence for apoptosis after intercerebral hemorrhage in rat striatum. J. Cereb. Blood Flow Metab. 20, 396-404.
24. Pike, B.R., Flint, J., Dave, J.R., Lu, X.C., Wang, K.K., Tortella, F.C., Hayes, R.L., 2004. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alpha II-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 24, 98-106.
25. Pineda, J.A., Lewis, S.B., Valadka, A.B., Papa, L., Hannay, H.J., Heaton, S.C., Demery, J.A., Liu, M.C., Aikman, J.M., Akle, V., Brophy, G.M., Tepas, J.J., Wang, K.K., Robertson, C.S., Hayes, R.L., 2007. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354-366.
26. Riederer, B.M., Zagon, I.S., Goodman, S.R., 1986. Brain spectrin (240/235) and brain spectrin (240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells. J. Cell Biol. 102, 2088-2097.
27. Takahashi, M., Chamczuk, A., Hong, Y., Jackowski, G., 1999. Rapid and sensitive immunoassay for the measurement of serum S100B using isoform-specific monoclonal antibody. Clin. Chem. 45, 1307-1311.
28. Wang, K.K., Posmantur, R., Nath, R., McGinnis, K., Whitton, M., Talanian, R.V., Glantz, S.B., Morrow, J.S., 1998. Simultaneous degradation of alpha II- and beta II-spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem. 273, 22490-22497.
29. Weiss, E.S., Wang, K.K., Allen, J.G., Blue, M.E., Nwakanma, L.U., Liu, M.C., Lange, M.S., Berrong, J., Wilson, M.A., Gott, V.L., Troncoso, J.C., Hayes, R.L., Johnston, M.V., Baumgartner, W.A., 2009. Alpha II-spectrin breakdown products serve as novel markers of brain injury severity in a canine model of hypothermic circulatory arrest. Ann. Thorac. Surg. 88, 543-550.
30. Whiteley, W., Chong, W.L., Sengupta, A., Sandercock, P., 2009. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 40, e380-e389.
31. Whiteley, W., 2011. Identifying blood biomarkers to improve the diagnosis of stroke. J. R. Coll. Physicians Edinb. 41, 152-154.
32. Wilkinson, K.D., Deshpande, S., Larsen, C.N., 1992. Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases. Biochem. Soc. Trans. 20, 631-637.
33. Wilkinson, K.D., 1997. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11, 1245-1256.